The Cyberknife, a linear accelerator mounted on a robotic device, enables excellent dose conformation to the target and minimizes dose to surrounding normal tissue. It is a very suitable device for performing hypofractionated stereotactic body radiotherapy (SBRT) as monotherapy for low to intermediate risk prostate cancer patients. We report our early experience using this technique.

Cyberknife, Hypofractionation, Prostate cancer, Radiotherapy
Nederlands Tijdschrift voor Urologie
Erasmus MC: University Medical Center Rotterdam

Aluwini, S, van Rooij, P.H, Kolkman-Deurloo, I.-K.K, & Bangma, C.H. (2010). Cyberknife stereotactic radiotherapy as monotherapy for low to intermediate stage prostate cancer: Early experience, feasibility and tolerance. Nederlands Tijdschrift voor Urologie, 18(1), 27–30. Retrieved from